At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 15 enrolled
Drug / intervention
Fluphenazine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ascending-Dose, Double-Blind, Placebo-Controlled, Study of Intralesional Fluphenazine Hydrochloride for Psoriasis
In Brief
A Phase 2 clinical trial evaluating Fluphenazine and Placebo for Psoriasis. Completed, enrolled 15 participants across 2 sites.
Detailed Summary
The objective of this study is to assess the safety and biologic activity of intralesional injection of fluphenazine in adult subjects with psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsImmune Control
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedJun 2009
Primary CompletionNov 2010
Study CompletionJan 2011
TodayJul 2026
First PostedJun 29, 2009
Enrollment StartNov 1, 2008
Primary CompletionNov 1, 2010
Study CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.0 years ago
Interventions
Fluphenazinedrug
Intralesional injection of Fluphenazine
Placebodrug
Intralesional injection of placebo